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Measles virus infection causes a profound immunosuppression. The basis for this immunosuppression is not known. This
immunosuppression could be due to virus acting directly on lymphoid cells, the production of an immunosuppressive viral
product, or a lymphoid product. We have developed an antigen-specific T cell system to study measles virus–T-cell
interactions. We demonstrate that as few as five infectious viral particles added to 1000 T cells results in profound inhibition
of antigen-specific T cell proliferation. Supernates taken from measles virus-infected T cells suppress the proliferation of
uninfected T cells. Measles-virus-infected HeLa or Vero cells do not produce the factor. The antiproliferative effects of the
supernates cannot be attributed to infectious virus, IL-10 or TGF-b. The soluble factor appears to be larger than 100 kDa, yet
retains antiproliferative activity following trypsin digestion with a size less than 10 kDa. Loss of activity is seen following heat
treatment at 56°C. The factor is lymphoid cell specific and exhibits cytokine-like behavior yet appears not to be a known
cytokine. This soluble factor may be responsible for the overt clinical immunosuppression seen in man and a previously
undescribed cytokine induced by measles virus infection of human lymphocytes. © 1998 Academic Press
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INTRODUCTION
Measles is most commonly associated with a rela-
tively benign childhood exanthem and febrile illness.
Most children in industrialized nations are immunized
against measles within the first 2 years of life. Yet, mea-
sles virus remains an important pathogen in underdevel-
oped countries, where it continues to kill 1–2 million
children a year (Sabin, 1991; Sieving, 1988). Some of
these deaths are the result of immunosuppression,
which renders children susceptible to opportunistic in-
fection in addition to the direct pathological conse-
quences of measles virus infection (Griffin et al., 1987;
Hirsch et al., 1984; McChesney and Oldstone, 1987; von
Pirquet, 1908). The basis for this immunosuppression is
not known. However, the infection of lymphoid cells and
the production of immunomodulatory factors by infected
cells or both contribute to the suppression.
Suppression of cell mediated responses by measles
virus has been recognized since 1908, when von Pirquet
(1908) reported that children who were positive for tuber-
culin antigen by skin test lost the ability to mount this
response during the course of an acute measles virus
infection. Subsequently, intentional measles virus infec-
tion was used as an immunosuppressive therapy for the
autoimmune disease lipoid nephrosis, since measles
virus infection resulted in remissions in afflicted patients
(Blumberg and Cassady, 1947). Peripheral blood mono-
nuclear cells (PBMCs) obtained from measles patients
were found not to respond to mitogen stimulation by PHA
(Fireman et al., 1969; Kadowaki et al., 1970). Similarly,
when PBMCs from children with tuberculosis were in-
fected in vitro with measles virus, and the PBMCs then
stimulated with purified protein derivative (PPD), there
was a marked decrease in blast transformation (Smith-
wick and Berkovich, 1966).
Very little is known about the cause of the immuno-
suppression. In order to better study this measles virus–
lymphocyte interaction, we have developed an in vitro
antigen-specific T cell proliferation assay to monitor vi-
rus-induced suppression (Bell et al., 1997; Burns et al.,
1983). The advantage of this system is that instead of
measuring antigen- or mitogen-induced proliferation of
bulk PBMCs, we can measure virus interactions with
antigen-specific CD41 T cells more akin to what von
Pirquet (1908) described for tuberculin unresponsive-
ness. This system allows detailed investigation of the
mechanism of suppression.
We initially characterized the effects of direct virus
infection on T cells and have demonstrated that virus
infection of antigen-specific CD41 T cells can suppress
antigen-specific T cell proliferation (Bell et al., 1997). In
addition, IL-4 production is decreased but IL-6, IL-10,
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IFN-g, and IL-2 production is relatively stable. Interest-
ingly, the IL-2Ra subunit is downregulated due to infec-
tion.
In our current experiments, we extend these findings
to demonstrate that: (1) Infection at very low multiplicities
of infection (m.o.i.) of CD4
1
T cells specific for PPD or
myelin basic protein (MBP) resulted in a substantial
decrease in proliferation of these cells versus our previ-
ous studies (Bell et al., 1997), where high m.o.i. were
used; (2) treatment of uninfected T cells with the super-
natant fluid from the infected T cell cultures resulted in a
marked decrease of antigen-stimulated and mitogen-
and superantigen-induced proliferation of the uninfected
T cells; (3) supernatant fluids did not contain infectious
virus and the suppressing factor was not IL-10 or TGF-b;
and (4) the antiproliferative factor was larger than 100
kDa and labile at 56°C for 30 min. These data indicate
that the soluble factor is not a conventional cytokine and
may represent a new cytokine with antiproliferative prop-
erties.
RESULTS
Suppression of proliferation
During the viremic phase of measles virus infection,
not all PBMCs are infected and contain detectable virus
(Forthal et al., 1992; Nakayama et al., 1995; van Binnen-
dijk et al., 1994; Whittle et al., 1978), yet mitogen-induced
proliferation is suppressed and antigen-specific re-
sponses are decreased (Fireman et al., 1969; Hirsch et
al., 1984; Kadowaki et al., 1970; Whittle et al., 1978).
Therefore, to better mirror this in vivo situation, we de-
termined the lowest level of infection of T cells that
would result in a decrease in proliferation. This is shown
in Table 1. PPD-specific T cells were infected with mea-
sles virus at an m.o.i. of 0.05 to 0.000005 (see Materials
and Methods). T cells were then activated by PPD pre-
sented by irradiated B cells as APCs and thymidine
incorporation was measured. Uninfected T cells cultured
with irradiated APC and PPD actively proliferated (stim-
ulation index is approximately 8: Table 1, row 2). At an
m.o.i. of 0.05 and 0.005 (5 PFU/100 cells and 5 PFU/1000
cells, respectively) there was a significant decrease in
[3H]thymidine incorporation (rows 3 and 4) by the in-
fected T cells. Even at a m.o.i. of 0.0005 (5 PFU/10,000
cells) there was a decrease in the T cells’ ability to
proliferate. Infection of a different T cell line resulted in a
similar inhibition of proliferation. These experiments
have been repeated with other T cell lines generated
from another individual with similar results.
In other experiments, our measles virus preparation
(2 3 107 PFU/ml) was subjected to UV irradiation and
plaque assays were performed. After UV treatment, no
infectious virus could be detected. We used this prepa-
ration to treat T cells at equivalent m.o.i. (prior to UV
irradiation) or a preparation of measles virus which was
subjected to the identical procedure but not UV irradi-
ated. UV-inactivated measles virus did not inhibit anti-
gen-specific T cell proliferation, while non-UV-treated
virus did (data not shown). Thus, the observed decrease
in proliferation is not T cell line specific, antigen specific,
or individual specific and was dependent on infectious
virus.
To determine the actual numbers of infected cells,
infectious center assays were performed. T cells were
infected at a m.o.i. of 0.005 and added to irradiated APCs
pulsed with antigen. Cultures were harvested on day 3
and infectious center assays conducted. Three assays
indicated that less than 3% of the T cells scored as
positive (range: 2.5/100 cells to less than 1/104 cells).
Measles virus has been reported to kill cells (Au-
waerter et al., 1996; Esolen et al., 1995; Nichols, 1963;
Nichols et al., 1964; Norrby et al., 1965). In order to
determine whether the decrease in proliferation was a
result of cell death, the following experiments were per-
formed. An antigen-specific T cell line was infected at
various m.o.i. (0.05–0.000005) and activated with PPD
under standard T cell proliferation conditions (see Ma-
terials and Methods). A noninfected T cell control (m.o.i.
5 0) was run in parallel. As shown in Table 2, no differ-
ences in viability were noted between the noninfected
(m.o.i.—0) and infected T cell lines. With the no-virus-
infected control, the percentage of viable cells was ap-
proximately 50% (Table 2, top row). There was essentially
no difference between the infected cultures and the no
virus control in percentage of viable cells. Similar data
were obtained using a MBP-specific T cell line. Thus,
under these conditions there was not a profound loss of
cell viability due to virus infection.
TABLE 1
Infection of T Cells Induces Suppression
of Antigen-Specific Proliferation
Cells Antigen m.o.i. cpm
1. T 1 Ba None 0 2,157 6 129
2. T 1 Ba PPD 0 16,826 6 406
3. T 1 Ba PPD 0.05 2,826 6 137
4. T 1 Ba PPD 0.005 4,998 6 193
5. T 1 Ba PPD 0.0005 10,187 6 494
6. T 1 Ba PPD 0.00005 18,330 6 526
7. T 1 Ba PPD 0.000005 17,289 6 373
Note. To measure proliferation, T cells were infected or mock in-
fected at the m.o.i. as indicated above on day 0. T cells were put into
culture overnight and washed three times. We used triplicate micro-
wells containing PPD reactive T cells (4 3 104 cells/well) and irradiated
APCs, with or without PPD (5 mg/ml). Cultures were pulsed with [3H]thy-
midine on day 3 and harvested on day 4. cpm were determined and are
presented above. The values shown represent the cpm [3H]thymidine
incorporation 6 SEM.
a B cells irradiated with 6000 rad.
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Suppression induced by supernatant factor
Since not all cells are infected yet proliferation was
decreased, we asked whether supernatant fluids from
measles virus-infected antigen-specific T cell cultures
had the ability to inhibit proliferation of noninfected an-
tigen-specific T cells. This experiment is diagrammed in
Fig. 1. On day 0, a PPD-specific T cell line was infected
at a m.o.i. of 0.005 or mock infected, washed three times,
and put into culture overnight. On day 1, T cells were
washed three more times and counted and autologous
irradiated B cells plus PPD were added. On day 3 super-
natant fluids were collected from the infected or mock-
infected T cell cultures. Parallel cultures were pulsed
with [3H]thymidine. On day 4, the T cell cultures were
harvested and counts per minute (cpm) determined. The
cpm was 1516 for the infected T cell culture and 9777 for
the mock-infected culture. Thus, there was a marked
suppression in the infected T cell cultures from which the
supernates were originally collected.
In the first supernate experiment, the supernatant flu-
ids from measles virus-infected T cells were added at
various dilutions to an uninfected PPD-specific T cell line
and the uninfected T cells stimulated with PPD pre-
sented by irradiated B cells as APCs. The results of this
experiment are shown in Table 3. Addition of supernatant
fluid from the infected T cell culture markedly sup-
pressed the proliferation of the uninfected T cells. In the
next experiment, the supernatant fluids from infected
PPD reactive T cells or mock-infected PPD reactive T
cells were added at various dilutions to a different
antigen-specific T cell line, specific for MBP and using
PBMCs as APCs. A similar inhibition of proliferation was
seen (data not shown). These experiments demonstrate
two points. The first is that the supernate has the ability
to suppress the proliferation of different uninfected anti-
gen-specific T cells. Thus, inhibition is not antigen spe-
cific. Second, inhibition of proliferation is observed
whether irradiated EBV B cells were used as APCs or
PBMCs were used as APCs. This basic experiment has
been repeated several times with similar results using
different T cell lines generating the supernates and using
T cell lines from different individuals.
To determine the relatively potency of the supernate
in suppressing proliferation, a dilution series was pre-
pared from 1/10 to 1/1000 (data not shown). Even at a
dilution of 1/1000 there was still potent suppression of
T cell proliferation induced by the supernate. Other
TABLE 2
No Overt Cell Death by Measles Virus Infection
m.o.i.
Day
2 3 4
0 47.6a 49.5 51.2
0.05 41.2 44.1 42.9
0.005 55.8 50.0 48.2
0.0005 51.6 41.2 46.9
0.00005 48.3 42.0 48.9
Note. T cells were infected with measles virus at a m.o.i. listed above
and extensively washed. T cells were then put into culture. The next
day (day 1) the T cells were washed three times and stimulated with
PPD presented by irradiated B cells (6000 rads). Cultures were har-
vested on days 2–4 and the percentage of viability was measured by
trypan blue exclusion.
a Percentage viable.
FIG. 1. T cells were infected at a m.o.i. of (0.005) with measles virus.
Virus was allowed to adsorb for 1 h and cells were washed three times
with PBS. The cells were resuspended in RPMI 1640 containing 10%
FBS. The next day (day 1) the T cells were washed three more times
with PBS, counted, and added to 96-well plates with irradiated APCs
and antigen (Ag). On day 3 supernatant fluids were collected from
infected and noninfected T cell cultures, and parallel T cell cultures
were pulsed with [3H]thymidine. Cells were harvested and incorpora-
tion of [3H]thymidine was determined.
TABLE 3
Suppression of Antigen-Specific Proliferation by Supernatant Fluid
from MV-Infected T Cells
Uninfected cells Antigen Supernate cpm
1. T 1 Ba None None 2,450 6 56
2. T 1 Ba PPD None 49,568 6 3172
3. T 1 Ba PPD 1/2 Uninfected 36,205 6 1514
4. T 1 Ba PPD 1/2 Infected 1,413 6 222
5. T 1 Ba PPD 1/4 Infected 816 6 85
6. T 1 Ba PPD 1/8 Infected 963 6 68
Note. To determine whether supernates inhibited antigen-induced T
cell proliferation, 4 3 104/well PPD reactive cells plus irradiated APCs
were cultured in triplicate microwells with or without PPD. Supernatant
fluids from infected T cell culture (m.o.i. 0.005) or mock-infected T cell
cultures were collected as described in Fig. 1. The supernates from
infected or mock-infected cultures were added at the dilutions shown.
Cultures were pulsed with [3H]thymidine on day 3 and harvested on
day 4. The cpm was determined and mean cpm 6 SEM is shown.
a B cells irradiated with 6000 rad.
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supernates derived from different T cell lines have
similar potency.
To ascertain whether T cells were killed by the addi-
tion of supernate, the viability of the T cells was moni-
tored (day 3). The addition of the supernatant fluid did not
kill the T cells in the cultures (data not shown). Thus,
there is no significant cell death in supernate-treated
cultures.
To determine whether the supernatant fluid needed to
be present during the entire proliferation assay (3 days),
the following experiments were performed. T cells were
incubated with supernatant fluid for 1 to 18 h and washed
three times. The T cells were then counted and APCs
added with antigen. Forty-eight hours later the cultures
were then pulsed with [3H]thymidine and harvested the
next day. Under these conditions, antigen-specific T cell
proliferation was not inhibited at 1 h after treatment but
was after 6 h (Table 4).
Similarly, IL-2-induced T cell proliferation was also
tested to determine whether this stimulus for prolifera-
tion could also be suppressed. When supernatant fluids
from infected T cell cultures were added and the cultures
were initiated, an inhibition of proliferation was observed
in infected versus control supernates (Table 5, Experi-
ment A). Interestingly, when T cells were incubated in
supernates from infected T cell cultures for 18 h, and
washed and IL-2 was added, there was no inhibition of
proliferation (Table 5, Experiment B). Thus, the factor
needed to be continuously present to inhibit IL-2-induced
proliferation.
It has been previously described that mitogen-in-
duced proliferation of PBMC is inhibited in patients
infected with natural measles or vaccinated (Kadowaki
et al., 1970; Smithwick and Berkovich, 1966). In order to
determine whether mitogen-induced proliferation was
inhibited by supernatant fluids from infected T cells,
PBMC from normal individuals were cultured in the
presence of PHA (1 mg/ml) or SEB (50 ng/ml) and
supernate. It was evident that T cell proliferation in-
duced by both PHA and SEB was reduced by 90% (data
not shown). Thus, the observation that PBMCs from
measles-virus-infected patients do not proliferate in
response to mitogens mirrors the in vitro inhibition
noted in our experiments.
Suppression of proliferation not due to infectious
virus
A question arises whether infectious virus present in
the supernates was responsible for the observed sup-
pression, since we demonstrated that very few infectious
virus particles can inhibit T cell proliferation (Table 1).
Therefore, supernatant fluids from infected T cells were
subjected to UV irradiation for up to 3 h. The supernatant
fluid was tested for infectious virus by viral plaque assay
and none could be detected. When this UV-treated su-
pernatant fluid was used in a proliferation assay, the
suppressive nature still was present since it inhibited the
proliferation of antigen-specific T cells (data not shown).
Even without prior UV irradiation, no infectious virus
TABLE 5
Inhibition of IL-2 Supported T Cell Proliferation by Supernatant
from Measles-Infected T Cells
Experiment Uninfected cells Supernate cpm 6 SEM
A 1. T alone None 53 6 12
2. T 1 IL2 None 9,905 6 414
3. T 1 IL2 1/10 Infected 2,634 6 64
4. T 1 IL2 1/25 Infected 1,866 6 134
5. T 1 IL2 1/50 Infected 2,970 6 142
6. T 1 IL2 1/100 Infected 3,044 6 102
7. T 1 IL2 1/10 Uninfected 9,008 6 341
B 1. T Alone None 58 6 9
2. T 1 IL2* None 12,726 6 83
3. T 1 IL2 1/10 Infected 12,601 6 337
4. T 1 IL2 1/25 Infected 12,011 6 789
5. T 1 IL2 1/50 Infected 11,108 6 299
6. T 1 IL2 1/100 Infected 12,600 6 30
7. T 1 IL2 1/10 Uninfected 13,613 6 763
Note. Experiment A: PPD-specific T cells were activated 5 days prior
to this assay to provide an IL-2-responsive T cell population. These T
cells were then incubated with medium alone, medium with 20 U/ml
IL-2, or medium with IL-2 plus supernate as indicated. Proliferation was
measured as previously described after 48 h. Experiment B: PPD-
specific T cells responsive to IL-2 were incubated with medium alone
or containing supernate from uninfected or infected T cell cultures for
18 h. T cells were then washed and incubated with medium containing
20 U/ml IL-2. Proliferation was measured after 48 h.
TABLE 4
Pretreatment of T Cells with Supernate Leads
to Inhibition of Proliferation
Time (h) Cells Antigen Supernateb cpm 6 SEM
1 T 1 Ba None None 2,574 6 76
T 1 Ba MBP Uninfected 59,401 6 3,106
T 1 Ba MBP Infected 61,162 6 3,321
6 T 1 Ba None None 2,241 6 113
T 1 Ba MBP Uninfected 16,040 6 948
T 1 Ba MBP Infected 1,587 6 104
12 T 1 Ba None None 2,280 6 101
T 1 Ba MBP Uninfected 29,572 6 864
T 1 Ba MBP Infected 1,507 6 21
18 T 1 Ba None None 2,153 6 250
T 1 Ba MBP Uninfected 48,482 6 600
T 1 Ba MBP Infected 1,115 6 27
Note. T cells reactive to MBP were incubated for 1 to 18 h in either
control supernate or supernate from measles-virus-infected cells. T
cells were then washed and used in proliferation assays.
a B cells were irradiated with 6000 rad and used as APCs.
b All supernates were subjected to UV and no detectable virus was
present.
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could be detected by viral plaque assay in the superna-
tant fluids used in these experiments.
To determine whether viral products generated by
infected T cells were likely to be mediators of this sup-
pression, HeLa and Vero cells were infected or mock
infected with measles virus at a m.o.i. of 0.005 and
supernatant fluids harvested 3 days later. Supernatant
fluids were subjected to 1 h of UV irradiation to eliminate
any infectious virus. Plaque assays of the supernatant
fluids confirmed that no infectious virus was detectable.
When these supernatant fluids were added to T cell
proliferation assays, using two different lines, no inhibi-
tion of proliferation was observed (data not shown).
Other supernatant fluids from HeLa and Vero cells gen-
erated independently at a different time did not inhibit
antigen-specific T cell proliferation.
Similarly, a neutralizing monoclonal antibody to mea-
sles virus hemagglutinin and SSPE serum containing
antibodies to all the measles virus structural proteins
was used to determine whether these antibodies could
influence the suppressive nature of the supernatant fluid.
No effect on the suppression of antigen-specific T cell
proliferation was observed when these antibodies were
added at any of the dilutions tested. These data suggest
that viral proteins are not directly responsible for the
inhibition of T cell proliferation induced by the super-
nates.
Inhibition of proliferation not due to IL-10 or TGF-b
Characterization of the supernatant fluid from infected
T cell lines was done. It is known that IL-10 and TGF-b
can suppress the proliferation of T cells and have been
associated with modulation of the immune response
(Kehrl et al., 1986; Taga and Tosato, 1992). Neutralizing
monoclonal antibodies to IL-10 and TGF-b were added to
the supernatant fluids to assess whether the suppres-
sive effects on T cell proliferation could be reversed. The
supernatant fluids continued to inhibit antigen-specific T
cell proliferation by greater than 90% in spite of the
addition of neutralizing antibodies (data not shown).
Thus, these data would suggest that the observed effect
was not due predominantly to the antiproliferative effects
of these cytokines.
A cytokine analysis was performed on the supernates
from measles-virus-infected T cell cultures and unin-
fected T cell cultures. This is shown in Table 6. IL-2, IL-4,
IL-10, IFN-g, and TNF-a were detected in the uninfected
supernate. Similar levels of these cytokines were
present in the infected supernate. Between the two su-
pernates, no obvious difference was found that could
explain the suppressive nature of the infected T cell
supernate.
To obtain an approximate size of the inhibitory factor,
a sample was subjected to gel filtration. The results of
this experiment suggested that the active component is
larger than 60 kDa. To obtain a size estimate by another
filtration technique, control and infected T cell super-
nates were separated into larger than 100 kDa and
smaller than 100 kDa fractions using filtration through
defined filters. The activity was contained in the fraction
larger than 100 kDa. This is shown in Table 7.
To determine the relative sensitivity of the inhibitory
activity to proteolysis, control supernatant fluid and su-
pernate from infected T cell cultures were treated with
trypsin (30 mg/ml) for 1 h at room temperature. Under
these conditions BSA contained in the samples (in the
FBS supplement) was completely digested, as deter-
mined by SDS–PAGE analysis (data not shown). Interest-
ingly, after trypsin treatment, the measles-virus-derived
supernate could still inhibit T cell proliferation (Table 8).
To ascertain whether the trypsin had actually cleaved the
inhibitory factor, the trypsinized samples were separated
into two fractions, one larger than 10 kDa and the other
smaller than 10 kDa, by membrane filtration. Both the
larger than 10 kDa and smaller than 10 kDa fractions
contained suppressive activity. This is shown in Table 8.
These data indicate that the suppressive factor was
susceptible to trypsin digestion, but the active moiety
was smaller than 10 kDa, representing less than 100
amino acids, and the active site was not trypsin sen-
sitive.
Functional activity associated with proteins often
can be inactivated by heating, as is seen with the
complement components. In dialysis studies, the an-
tiproliferative activity was stable upon incubation at
4°C for 24 h (data not shown). To further determine its
thermal stability, supernatant fluids were incubated for
30 min at 0°, 37°, 42°, 56°, or 100°C and ability to
suppress antigen-specific T cell proliferation was
measured. The ability to inhibit antigen-specific T cell
TABLE 6
Cytokine Generation by Activated, Measles-Virus-Infected,
and Noninfected MBP Reactive T Cells
Measles
infection
Cytokine generation (pg/ml)
IL-2 IL-4 IL-10 IFN-g a TNF-a TGF-b
Infected 184 16 68 12 8 .10
Uninfected 216 25 54 32 34 .10
Note. T cells reactive with MBP were infected with measles virus at
m.o.i. 5 0.005 or were mock infected. The cells were activated by
culture with MBP—30 mg/ml with irradiated APC. Culture supernatants
collected at 72 h were UV-inactivated and frozen until assayed for
cytokine livels or for suppressive activity. Supernatants from infected T
cells inhibited proliferation of PPD reactive T cells by at least 80%, while
supernatants from noninfected T cells produced no inhibition.
a The lymphokine values shown were determined by ELISA and
represent pg/ml, except for IFN-g as ng/ml.
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proliferation was completely abrogated at 56°C (data
not shown).
DISCUSSION
In this paper we report new observations concerning
measles-virus-induced suppression. First, we clearly es-
tablish that low level measles virus infection is capable
of inhibiting antigen-specific T cell proliferation. These
levels of in vitro infection are similar to those reported
during the viremic phase of measles virus infection
(Forthal et al., 1992; Nakayama et al., 1995; van Binnen-
dijk et al., 1994; Whittle et al., 1978). This is in the order
of 5 PFU for 100–10,000 T cells. Second, we find that the
inhibition of proliferation is mediated by virus-free super-
natant fluids from these infected T cell cultures. Third,
the inhibition of proliferation is not mediated by INF-g,
IL-10, or TGF-b, and the factor appears to be larger than
100 kDa.
In order to demonstrate these points, we established
human CD41 antigen-specific T cell lines responding to
PPD and MBP (Burns et al., 1983). We have previously
reported the effects of measles infection of these T cells
lines using a high m.o.i. of 1–3, where most T cells were
infected (Bell et al., 1997). In the current paper, we use a
m.o.i. of 0.05 to 0.000005, which approximates the level
of infection reported during viremia in infected individu-
als. During the viremic stage, measles virus is primarily
cell-associated in both natural infection of humans and
experimental infection of monkeys (Forthal et al., 1992;
Hicks et al., 1977; Ihara et al., 1992; Ruckle and Rogers,
1957; van Binnendijk et al., 1994). As early as the late
1970s when studying the lymphocyte cell populations
infected during viremia, Whittle et al. (1978) found
that approximately 37% of PHA-stimulated T cells from
PBMCs of patients during the acute stage of disease
(early rash) were positive for measles virus antigens, as
determined by immunofluorescent staining. Similarly,
they saw 7% of B cells antigen positive for measles virus
(Whittle et al., 1978). More recently, Nakayama et al.
(1995) detected measles virus genome in CD41 and
CD81 T cells, B cells, and monocyte/macrophages by
RT–PCR during the rash phase.
TABLE 7
The Size of the Active Component in the Supernate Is Larger Than 100 kDa
Uninfected cells Antigen Supernate cpm 6 SEM
1. T 1 Ba None None 1,743 6 77
2. T 1 Ba MBP None 40,349 6 1,072
3. T 1 Ba MBP 1/50 Infected MW .100 kDa 4,120 6 171
4. T 1 Ba MBP 1/50 Infected MW ,100 kDa 40,472 6 879
5. T 1 Ba MBP 1/50 Uninfected MW .100 kDa 54,616 6 2,290
6. T 1 Ba MBP 1/50 Uninfected MW ,100 kDa 57,301 6 1,924
Note. T cells reactive with MBP, 3 3 103 well, and an equal number of irradiated, autologous EBV-transformed B cells were plated in triplicate for
these assays. MBP—30 mg/ml and supernate were added as indicated. Proliferation was measured at 72 h following addition of [3H]thymidine and
shown as cpm 6 SEM.
a Irradiated with 6000 rad.
TABLE 8
Trypsinization Results in Suppressive Activity of Less Than 10 kDa
Infected cells Antigen Supernate cmp 6 SEM
1. T 1 PBMCa None None 4,103 6 36
2. T 1 PBMCa PPD None 31,196 6 1,544
3. T 1 PBMCa PPD 1/100 Infected 2,440 6 117
4. T 1 PBMCa PPD 1/1,000 Infected 12,215 6 2,034
5. T 1 PBMCa PPD 1/100 Infected 1 trypsin 1,435 6 60
6. T 1 PBMCa PPD 1/1,000 Infected 1 trypsin 2,324 6 466
7. T 1 PBMCa PPD 1/100 Infected 1 trypsin MW .10 kDa 2,215 6 247
8. T 1 PBMCa PPD 1/100 Infected 1 trypsin MW ,10 kDa 1,517 6 139
9. T 1 PBMCa PPD 1/100 Buffer 1 trypsin 21,079 6 113
Note. T cells reactive with PPD, 3 3 103/well, and autologous, irradiated PBMC, 1 3 105/well, were plated in triplicate for these assays. PPD-3 mg/ml
and supernate were added as indicated. Some samples of supernate were treated with trypsin followed by inactivation of the trypsin as described
under Materials and Methods. Proliferation was measured at 72 h following addition of [3H]thymidine and is shown as cpm 6 SEM.
a Irradiated with 4000 rad.
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Forthal et al. (1992) found that in all patients (8/8),
PBMCs were found to contain infectious virus early
during the rash state and that four of six patients were
still viremic 6 to 7 days after the onset of the rash. They
suggested that measles-virus-infected patients may
have a prolonged viremia and a large proportion of
PBMCs were infected. In their study, the proportion of
infected PBMCs ranged from 3 to 5623 TCID50/10
5
PBMCs (Forthal et al., 1992). In other studies, Osterhaus
and colleagues found that infection of cynomolgus mon-
keys with a wild-type strain of measles virus resulted in
1/100 to 1/333 PBMCs being infected during the viremic
stage (van Binnendijk et al., 1994). Thus, during the rash
and viremic stages of illness, measles virus has been
found in all cell types comprising the PBMC population.
In addition, the proportion of PBMCs which were infected
was never more than 40% and could be as low as 3/105.
It has also been shown that measles virus can infect T
cells, B cells, and monocytes/macrophages in vitro (Jo-
seph et al., 1975; Sullivan et al., 1975; Zweiman, 1971). In
our in vitro experiments, the numbers of infected cells as
determined by infectious center assays were less than 3
in 100 cells.
A soluble factor with antiproliferative activity could
account for these observations where there was a
marked suppression of T cell proliferation. We demon-
strated that infected T cells secrete a soluble factor with
antiproliferative activity. In our studies inactivated mea-
sles virus did not suppress proliferation of antigen-spe-
cific T cell proliferation. In addition, our supernatant flu-
ids inhibited proliferation even at dilutions of 1:1000,
suggesting that conventional cytokines such as the IFNs
are not involved, since relatively high amounts of type 1
IFN (a or b) 10 U/ml or greater are needed to inhibit T cell
proliferation (Holan et al., 1992; Rudick et al., 1993; Soos
and Johnson, 1995).
Our size determinations of the soluble factor suggest
that this may be an undescribed cytokine with antiprolif-
erative properties. IL-10 and TGF-b have been reported
to inhibit T cell proliferation (Ahuja et al., 1993; Bejarano
et al., 1992; de Waal-Malefyt et al., 1991; Ding and She-
vach, 1992; Fox et al., 1992; Inge et al., 1992; Su et al.,
1991; Taga and Tosato, 1992). We have ruled out IL-10
and TGF-b as potential candidates. INF-a and -b have
also been reported to inhibit cell proliferation. Human
IFN-a has an apparent molecular weight of 16–27 kDa.
Human IFN-b has an apparent molecular weight of 20
kDa. Our current size estimates would indicate that our
factor is too large to be one of the IFNs. In addition, since
infected HeLa cells do not produce the factor, this would
also tend to rule out IFN-a and IFN-b.
To determine whether one of the structural proteins
of measles virus is responsible for these effects, poly-
clonal and monoclonal antibodies to measles virus
were utilized to treat the supernates. This did not
lessen the antiproliferative effects, suggesting that
viral products are not responsible. This would suggest
that the inhibition of T cell proliferation was not due to
one of the structural protein of measles virus and not
dependent on the viral hemagglutinin. Schlender et al.
(1996) have reported that inhibition of proliferation of
PBMCs was due to interactions with both the measles
virus hemagglutinin and fusion protein with uninfected
PBMC. Contact was needed with their infected cell
population and the responding PBMC population. They
indicated that suppression of proliferation was not due
to soluble factors produced by the infected PBMCs.
These investigators used a low m.o.i. to infect PBMCs
but did not measure infectious centers. Our data indi-
cate that inhibition of proliferation in our antigen-spe-
cific system acts by a different mechanism. Infectious
virus is required for the generation of the soluble
factor and UV-inactivated virus does not inhibit anti-
gen-specific T cell proliferation.
We have found that T and B cells, but not HeLa or Vero
cells, produce the inhibitory factor. This suggests that
lymphoid cells produce the factor or a viral product only
produced in lymphoid cells is responsible for the inhibi-
tion of proliferation. Most likely, the factor represents a
new cytokine with antiproliferative activity. Our current
experiments suggest that if it is a viral component, it is
not a conventional viral product. A potential candidate
band(s) has been observed, and we are attempting to
obtain enough material to sequence the band. We have
preliminary data that indicate eluted material from SDS
gels retains the antiproliferative activity.
As a measure of virus-induced immunosuppression,
investigators for the past 30 years have emphasized
the inhibition by measles virus of mitogen-induced
responses and bulk PBMC populations. We have de-
veloped an antigen-specific system to dissect the con-
tribution of measles virus infection (direct or indirect)
on the T cell, B cell, and/or monocyte/macrophage.
This is a physiologic in vitro model to study measles
virus modulation of immune responsiveness. Further
studies of the molecular basis of the suppressive
factor produced by infected cells should provide leads
for our understanding in the immunosuppression in-
duced by measles virus.
MATERIALS AND METHODS
Antigen-specific T cell lines
PBMCs were obtained from healthy volunteers using
Histopaque-1066 (Sigma, St. Louis, MO). Antigen-spe-
cific T cell lines were isolated as previously described
(Bell et al., 1997; Burns et al., 1983). Briefly, T cell lines
were generated by culturing fresh PBMCs (3 3 106 cells/
well) with antigen (PPD 5 mg/ml, Serum Institute, Copen-
hagen, Denmark) or myelin basic protein (MBP 30 mg/ml)
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in 24-well plates. One to two weeks later, these primary
cultures were observed and proliferating wells harvested
and restimulated with either PPD or MBP presented by
irradiated (4000 rad) autologous PBMCs as APCs. Cul-
tures that showed antigen-specific proliferation was
maintained with the addition of recombinant human IL-2,
20 U/ml (Chiron, Emeryville, CA). Antigen-specific prolif-
eration was assessed by [3H]thymidine incorporation
(0.5 mCi/well) in response to stimulation with antigen.
Cultured T cell lines were CD41, as determined by flow
cytometry (Becton–Dickinson FACScan flow cytometer).
Infection, proliferation assays, and supernatant fluids
T cells were infected with measles virus by incuba-
tion with the Edmonston strain (American Type Culture
Collection, Rockville, MD) at the stated m.o.i. (see
Results) at 37°C for 1 h (Whittle et al., 1978). Control T
cells were mock infected and incubated at 37°C for
1 h. Cells were then washed three times with PBS,
resuspended in RPMI 1640 (Gibco/BRL, Grand Island,
NY) supplemented with 10% FCS (Gibco/BRL) and 1%
antibiotics (MediaTech, Herndon, VA), and incubated
overnight at 37°C. T cells were washed three more
times and the viability of cells in parallel infected and
uninfected cultures was confirmed by trypan blue ex-
clusion, prior to stimulation and at various intervals
throughout the experimental period.
To determine antigen-induced proliferation, antigen-
specific T lymphocytes (infected or uninfected) were cul-
tured in triplicate at 3–5 3 104 cells/well with autologous
antigen presenting cells (APCs) in 96-well plates. These
were either irradiated Epstein–Barr virus-transformed B
cells (EBV-B cells) (3–5 3 104cells/well) or freshly iso-
lated autologous irradiated PBMC (1 3 105 cells/well), as
indicated. Antigen, either MBP (30 mg/ml) or PPD (5
mg/ml) was added to selected microwells. Cultures were
assayed for proliferation by pulsing with [3H]thymidine
(New England Nuclear, Wilmington, DE) for the final
18–24 h of a 72-h proliferation assay.
Supernatant fluids were collected on the 3rd day of
culture (day 3) and frozen at 270°C until used. In some
experiments supernates were subjected to a Philips ster-
ile guard G36T6L UV source at a distance of 7.5 cm for 45
min to 3 h. Forty-five minutes under these conditions
reduced the infectivity of measles virus from 107 PFU to
undetectable levels. The lower limits of our assay were 5
PFU/ml.
In some experiments, neutralizing antibody to IL-10 or
TGF-b was added to the supernatant fluids (2.5 mg anti-
body/ml) to determine whether the factor suppressing T cell
proliferation was either of these cytokines. For IL-10, this
concentration of antibody could neutralize over 5 ng/ml of
IL-10. Similarly, this concentration of anti-TGF-b results in a
50% neutralization of 0.25 ng/ml TGF-b. These antibodies
were obtained from R&D Systems (Cat. Nos. MAB217 and
MAB240, respectively, Minneapolis, MN).
Cytokine assays
Cytokine generation was measured by standard ELISA
techniques. T cells were used in the assays at least 7
days following the previous activation. T cells, either
infected as previously described (Bell et al., 1997), or
control T cells, were washed and added to irradiated,
autologous PBMC either with or without added MBP—30
mg/ml. Supernatants were collected at 24 and 48 h for
measurement of cytokines and frozen at 220°C until
studied. The higher value of the two samples from each
T cell population is shown. Column fractions were col-
lected and frozen as above. The Cytokine Core Labora-
tory at the University of Maryland measured cytokines in
duplicate with controls using reagents from Endogen.
The limit of detection ranged from 5 to 10 pg/ml for the
cytokines tested.
Measles virus plaque and infectious center assays
Virus was diluted in PBS containing 3% FCS and 1%
antibiotics. Tenfold serial dilutions were made and 200
ml was added to confluent Vero cell monolayers in six-
well cluster plates (Costar, Pleasanton, CA). Virus was
allowed to adsorb for 1 h at 37°C in a humidified incu-
bator in a 5% CO2 atmosphere. Cluster plates were
rocked every 10–15 min and fluid was aspirated after 1 h
and a 3-ml overlay medium (Medium 199 (Gibco), con-
taining 1% antibiotics and 10% FCS) added. Cells were
incubated for 6 days at 37°C in a humidified incubator in
a 5% CO2 atmosphere, at which time cell monolayers
were stained with neutral red and plaques enumerated
(Fujinami and Oldstone, 1981). For the detection of infec-
tious centers, T cells were counted and divided into two
aliquots. In the first aliquot, the cells were diluted and
added directly to Vero cell monolayers. Cells in the sec-
ond aliquot were frozen–thawed three times and the
lysate diluted and allowed to adsorb to Vero cell mono-
layers for 1 h. As above, the fluid was aspirated and an
agarose overlay added. Plaques were counted on day 6
after staining with neutral red.
Treatment of the supernates
Dialysis of the supernate was performed as followed.
Five hundred microliters of supernate was placed in a
dialysis bag with a molecular weight cutoff of 10 kDa
(Spectophor, Los Angeles, CA) or in an Eppendorf tube.
The sample in dialysis membrane was placed in 2 liters
of PBS. The other sample was placed next to it, both at
4°C. The PBS was changed twice over a 24-h period.
Samples were then frozen at 220°C until used.
Supernates were subjected to size fractionation by gel
filtration using Sephadex G-100 (Pharmacia, Upsula,
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Sweden). Five hundred microliters of supernate was
added to a 30-cm column, PBS used as buffer, and 1-ml
factions were collected. Samples were filtered using a
0.2-mm filter and assayed in the antigen-specific T cell
proliferation assay. The column was standardized using
carbonic anhydrase II (29.0 kDa), bovine serum albumin
(66 kDa), and alcohol dehydrogenase (150 kDa) as mark-
ers (Sigma, St. Louis, MO).
For thermal stability measurements, 100-ml aliquots of
supernate were placed in Eppendorf tubes and put into
water baths at 0°, 37°, 42°, 56°, and 100°C for 30 min.
After the incubation, samples were immediately frozen
and placed in a 220°C freezer until used.
For trypsin sensitivity studies, 200-ml supernates from
infected or mock-infected cultures were adjusted to a
total trypsin concentration of 30 mg/ml (Sigma, Cat. No.
T8003). These were incubated at room temperature for
60 min and samples were mixed with 200 ml of FCS to
inactivate the trypsin. Samples were then divided into
aliquots and portions separated by Microcon filtration
(Amicon Inc., Beverly, MA) into . or ,10,000- and
. or ,100,000-kDa fractions. Dilutions of these factions
were tested in the antigen-specific proliferation assay.
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